T1	Pharmacological_substance 39 51	gatifloxacin
N1000 	Reference T1 MeSH:C078049	gatifloxacin
T2	Disorder 81 103	pulmonary tuberculosis
N1 	Reference T2 UMLS:C0041327	pulmonary tuberculosis
T3	Pharmacological_substance 168 180	gatifloxacin
N1001 	Reference T3 MeSH:C078049	gatifloxacin
T4	Pharmacological_substance 186 194	rifampin
N1002 	Reference T4 MeSH:D012293	rifampin
T5	Pharmacological_substance 196 205	isoniazid
N1003 	Reference T5 MeSH:D007538	isoniazid
T6	Pharmacological_substance 211 223	pyrazinamide
N1004 	Reference T6 MeSH:D011718	pyrazinamide
T7	Disorder 264 276	tuberculosis
N2 	Reference T7 UMLS:C0041296	tuberculosis
T8	Pharmacological_substance 366 378	gatifloxacin
N1005 	Reference T8 MeSH:C078049	gatifloxacin
T10	Pharmacological_substance 512 524	gatifloxacin
N1006 	Reference T10 MeSH:C078049	gatifloxacin
T11	Disorder 585 622	drug-sensitive pulmonary tuberculosis
T12	Pharmacological_substance 676 688	gatifloxacin
N1007 	Reference T12 MeSH:C078049	gatifloxacin
T13	Pharmacological_substance 828 840	gatifloxacin
N1008 	Reference T13 MeSH:C078049	gatifloxacin
T15	Pharmacological_substance 1112 1124	gatifloxacin
N1009 	Reference T15 MeSH:C078049	gatifloxacin
T21	Pharmacological_substance 1487 1499	gatifloxacin
N1010 	Reference T21 MeSH:C078049	gatifloxacin
T23	Pharmacological_substance 1566 1574	rifampin
N1011 	Reference T23 MeSH:D012293	rifampin
T24	Pharmacological_substance 1576 1585	isoniazid
N1012 	Reference T24 MeSH:D007538	isoniazid
T25	Pharmacological_substance 1591 1603	pyrazinamide
N1013 	Reference T25 MeSH:D011718	pyrazinamide
T26	Pharmacological_substance 1651 1663	gatifloxacin
N1014 	Reference T26 MeSH:C078049	gatifloxacin
T9	Subject 887 897	169 adults
T18	Subject 104 112	patients
T22	Speculation_cue 0 10	Evaluation
T30	Speculation_cue 233 242	evaluated
T31	Combination 207 210	and
T33	Subject 555 563	patients
T39	Combination 1561 1565	with
